InfuSystem Holdings, Inc.
AMEX:INFUMedical - Instruments & Supplies
Healthcare
$14.06 +4.00%
+$0.35 today
- Market cap
- $281.67M
- Beta
- 1.42
- P/E (TTM)
- 23.2
- EPS (TTM)
- $0.39
52W Low $5.38High $11.04
Volume 0.19M
Average 0.16M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$24.41M
FY 2025 · Annual
+19.3% YoYInvesting Cash Flow
-$6.79M
FY 2025 · Annual
Financing Cash Flow
-$14.96M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.42M | 18K | 872K | 2.35M | 6.63M |
| Depreciation & Amortization | 14.63M | 13.36M | 12.51M | 12.5M | 13.29M |
| Deferred Income Tax | (153K) | 19K | 633K | 1.92M | 2.73M |
| Stock-Based Compensation | 6.4M | 3.83M | 4.07M | 4.46M | 4.36M |
| Change in Working Capital | (2.69M) | 385K | (5.56M) | 652K | (94K) |
| Accounts Receivables | 829K | (1.15M) | (2.36M) | (701K) | 263K |
| Inventory | (864K) | (882K) | (1.58M) | (126K) | 1.14M |
| Accounts Payables | (2.36M) | 2.94M | 2.42M | (676K) | (708K) |
| Other Working Capital | (294K) | (522K) | (4.03M) | 2.16M | (789K) |
| Other Non-Cash Items | (1.29M) | (90K) | (1.3M) | (1.42M) | (2.51M) |
| Operating Cash Flow | 18.32M | 17.52M | 11.22M | 20.46M | 24.41M |
| Capital Expenditures | (16.66M) | (15.08M) | (11.12M) | (17.83M) | (560K) |
| Acquisitions (Net) | (7.98M) | 3.6M | 4.38M | 4.59M | (1.41M) |
| Purchases of Investments | 0 | (14.09M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 10.5M | 0 | 0 | 0 |
| Other Investing Activities | 3.32M | 3.6M | 4.38M | (12.15M) | (4.82M) |
| Investing Cash Flow | (21.32M) | (11.48M) | (6.73M) | (13.24M) | (6.79M) |
| Debt Repayment | (5.47M) | (13K) | (3.95M) | (5.32M) | (4.32M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 335K |
| Common Stock Repurchased | (1.73M) | (6.65M) | (1.31M) | (2M) | (10.97M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 738K | 605K | 835K | 387K | 0 |
| Financing Cash Flow | (6.46M) | (6.06M) | (4.42M) | (6.92M) | (14.96M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (9.46M) | (21K) | 66K | 296K | 2.66M |
| Free Cash Flow | 1.66M | 2.44M | 106K | 2.63M | 23.85M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$6.6M
+ D&A$13.3M
+ Stock-Based Comp$4.4M
+ Deferred Tax$2.7M
- Working Capital-$94.0K
- Other Non-Cash-$2.5M
= Operating Cash Flow$24.4M
- Capex-$560.0K
= Free Cash Flow$23.8M
Analysis
FY2025 free cash flow is $23.8M. FCF conversion is 359.9% of net income. Operating cash flow was $24.4M, with capex of -$560.0K. The largest bridge item is D&A at $13.3M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 8-K | Current report | Nov 3, 2026 | |
| 8-K | Current report | Oct 27, 2026 |
Does INFU generate free cash flow?
InfuSystem Holdings, Inc. (INFU) generated $23.85M of free cash flow in fiscal 2025.
How much operating cash flow does INFU produce?
Operating cash flow was $24.41M, before capital expenditures of $560,000.00.
Continue the stock analysis
Jump to another research area for this company.